A Study on the Effects of Cysteinyl Leukotriene Receptor Antagonist and Dexamethasone on the Transcription Level of Arginase - I in Asthmatic Mouse Models

TENG Hong,HU Min,LIU Chuntao,LIU Yue-Jian,LIANG Zong-an
2007-01-01
Abstract:Objective To evaluate the intervening effects of montelukast(MK) and dexam-ethasone(DXM) on the mediator of asthma, such as Arginase- I , in asthmatic mice models by investigating the pathological features of asthma, hyperplasia of goblet cells and smooth muscles, subepithelial fibrosis and submucosal vascular proliferation. Methods BALB/c mice, sensitized with ovalbumin conjuncted with Al(OH)3, then challenged with repeated exposure to aerosolized o-valburnin. Mice were randomly divided intothe control, asthmatic, MK, and DXM group. The thickness of the smooth muscle (WAm) of intrapulmonary bronchi was measured by image analysis system, and alcianblue staining to identify airway goblet cells. mRNA levels for arginase- I were determined by RT-PCR. Results Obvious infiltration of inflammatory cells and proliferation of goblet cells and smooth muscles were demonstrated in mouse bronchus. Transcription levels of arginase-I in the lung tissue were significantly higherthan those of the control group. Compared with asthmatic group, there was mild inflammation and collagen deposition in MK-treated and DXM - treated groups while no significant differences between treated groups and control were found . Repeated exposure of allergen induced airway inflammation and remodeling . Arginase-I plays an important role in the process of airway remodeling. DXM intervention could inhibit airway remodeling by way of reducing the levels of arginase- I .
What problem does this paper attempt to address?